The drug received accelerated approval in October 2017 as monotherapy for adults with MCL who have received at least one ...

Ann LaCasce, MD, MMSc, delved into some of the most recent advances in the lymphoma space, exploring how these new therapies ...

Lisandro Martínez suffered a serious looking knee injury as a toothless Manchester United slumped to their fifth Premier ...

Lisandro Martinez was left in tears as he was stretchered off with a serious-looking injury. The Manchester United star was ...

The Bruton tyrosine kinase inhibitor was approved in combination with bendamustine and rituximab in previously untreated mantle cell lymphoma (MCL ... for the treatment of unresectable or ...

Manchester United defender Lisandro Martínez was carried off the field in tears after suffering what appeared to be a serious ...

There is always the potential to cause more damage. ACLs are often injured along with a medial ligament (MCL) strain and a ...

Bristol Myers Squibb today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Breyanzi® (lisocabtagene maraleucel; ...

Biosciences receives US FDA orphan drug designation for MB-105 to treat relapsed/refractory CD5-positive T-cell lymphoma: Houston Thursday, January 30, 2025, 17:00 Hrs [IST] ...

Company prepares to advance to Phase 2 clinical trial in early 2025HOUSTON, Jan. 28, 2025 (GLOBE NEWSWIRE) -- March Biosciences (March Bio), an ...

Getting your Trinity Audio player ready... Norwood water customers recently received notification about a violation of ...